10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance of small-cap stocks.
Viridian Therapeutics Inc. (VRDN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Soleus Capital Guy Levy | 0 | $0 | 0% | |
| 4. | Driehaus Capital Richard Driehaus | 0 | $0 | 0% | |
| 5. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.41 | 5,000 | $117,050.00 | 6,000 | 2024-09-27 | Filing | |
| $23.33 | 21,400 | $499,262.00 | 21,400 | 2024-09-27 | Filing | |
| $18.75 | 1,600,000 | $30,000,000.00 | 3,445,813 | 2024-09-13 | Filing | |
| $21.00 | 476,190 | $9,999,990.00 | 1,839,954 | 2024-01-22 | Filing | |
| $25.37 | 4,000 | $101,478.80 | 259,500 | 2023-04-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.35 | 27 | $765.45 | 29,971 | 2023-06-16 | Filing | |
| $28.02 | 2,269 | $63,577.38 | 29,971 | 2023-06-15 | Filing | |
| $25.02 | 5,126 | $128,252.52 | 29,971 | 2023-06-06 | Filing | |
| $25.03 | 499 | $12,489.97 | 29,971 | 2023-06-05 | Filing | |
| $24.21 | 1,875 | $45,393.75 | 29,971 | 2023-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript
Viridian Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.00079, expectations were $-1.07.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Viridian Therapeutics First Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, King Street Capital Management, Light Street Capital Management, Better Therapeutics Inc (BTTX), Nogin, Inc. (NOGN), and More
Harvard University wants us to bow down to the exceptional generosity of Kenneth C. Griffin, a hedge fund billionaire who just made a $300-million gift to the school’s graduate program.
Billionaire Hedge Funds
